Sanofi

Sanofi, GSK Get Indian Approval for Late-Stage Trial of COVID-19 Vaccine

Cooperation Made the Vaccines, But Capitalism Will Extend the Pandemic

COVID-19: Can We Push Pharma Innovation Without Giving Away Pricey Patents?

A health worker shows unused packs of anti-dengue vaccine Dengvaxia before returning it inside a freezer for storage at the Manila Health Department in Sta Cruz, metro Manila, Philippines December 5, 2017. Credit: Reuters/Romeo Ranoco

How Sanofi’s Setback Could Lead to Better Dengue Vaccines

Concepcion Yusop, a national immunization program manager, shows an anti-dengue vaccine Dengvaxia inside a vaccine storage room in Sta. Cruz city, Metro Manila, Philippines December 4, 2017. Credit: Reuters/Romeo Ranoco

Philippines Authorities Stop Sale of French Dengue Vaccine Due to Health Risk